Wafik S. El-Deiry, M.D., Ph.D.
Penn State University, Hershey, PA
Cancer Biology & Therapy offers a highly competitive open access fee for authors who wish for free access to and distribution of published articles. Authors retain copyright of their work by utilizing a Creative Commons attribution license. Open Access papers will be submitted to PubMed Central immediately upon final publication of each issue.
The cost to make an original research paper OA is $750.00 USD.
For all other types of papers, the OA fee is $500.00 USD.
Cancer News Daily - an aggregate news source of the most up-to-date cancer research
Download a PowerPoint presentation about Cancer Biology & Therapy. Created 04.16.2011, 5.9 MB
Update on guidelines for duplicate publications and guidelines for plagiarism; 05.15.2009
Plagiarism is Not Acceptable in Science or for Cancer Biology & Therapy; 06.2005
CB&T archives (published online for one year or longer) are freely available to all users. Full-text access is available via a link on the abstract page of each paper.
The role of Snail in prostate cancer. Smith and Odero-Marah. Cell Adhesion & Migration 6(5): September/October 2012. (Review)
Heterogeneous epigenetic regulation of TIMP3 in prostate cancer. Shinojima et al. Epigenetics 7(11); November 2012.
Detection of promoter methylation of tumor suppressor genes in serum DNA of breast cancer cases and benign breast disease controls. Sturgeon et al. Epigenetics 7(11); November 2012.
Study on the association of helicobacter species with viral hepatitis-induced hepatocellular carcinoma. Krüttgen et al. Gut Microbes 3(3). May/June 2012.
Understanding the role of stromal fibroblasts in cancer progression. Tripathi, Billet and Bhowmick. Cell Adhesion & Migration 6(3). May/June 2012. Review.
Epigenetic deregulation of miR-29a and miR-1256 by isoflavone contributes to the inhibition of prostate cancer cell growth and invasion. Li et al. Epigenetics 7(8). August 2012.